Clinical Trial Update: Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of GSK1014802 on electrical hyperalgesia and threshold tracking in healthy volunteers; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• GSK1014802

Snippet

Sponsor: Biogen | Conditions: Pain, Neuropathic, Neuropathic Pain | Phase 1 | Status: TERMINATED